Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Merge Healthcare Incorporated (NASDAQ: MRGE) acted responsibly on behalf of investors’ profitability in the planned $1 billion sale to International Business Machines Corporation (NYSE: IBM). 

On August 6, 2015, Merge Healthcare Incorporated (NASDAQ: MRGE) and International Business Machines Corporation (NYSE: IBM)announced that they had entered into a merger agreement. Under the terms of the merger agreement, IBM will offer Merge shareholders $7.13 per share in cash for all outstanding shares.     

Based in Chicago, IL, and founded in 1987 Merge Healthcare Incorporated develops software solutions that allow different healthcare entities to share images to improve the electronic healthcare experience for patients and physicians worldwide. 

The investigation focuses on whether NASDAQ: MRGE investors received the highest price and whether the directors of Merge Healthcare Incorporated acted in the best interest of Merge Healthcare Incorporated company and its shareholders.    

If you purchased Merge Healthcare Incorporated (NASDAQ: MRGE) prior to August 6, 2015, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324. 

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185